AnaptysBio Inc. (ANAB)
NASDAQ: ANAB
· Real-Time Price · USD
20.36
0.21 (1.04%)
At close: Aug 21, 2025, 3:59 PM
20.34
-0.10%
After-hours: Aug 21, 2025, 06:54 PM EDT
AnaptysBio Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 123.16M | 111.87M | 91.28M | 57.17M | 30.47M | 22.96M | 17.16M | 14.96M | 12.94M | 10.69M | 10.29M | 4.49M | 24.09M | 52.9M | 63.17M | 122.16M | 101.27M | 71.25M |
Cost of Revenue | 1.2M | 1.19M | 1.8M | 2.4M | 2.4M | 2.39M | 2.38M | 2.38M | 2.37M | 2.35M | 2.33M | 28.5M | 50.14M | 74.88M | 98.5M | 93.29M | 90.61M | 83.24M |
Gross Profit | 121.97M | 110.68M | 89.48M | 54.77M | 28.08M | 20.57M | 14.78M | 12.58M | 10.56M | 8.34M | 7.95M | -24.02M | -26.05M | -21.99M | -35.32M | 28.88M | 10.67M | -11.99M |
Operating Income | -86.14M | -100.29M | -114.95M | -147.41M | -162.39M | -162.21M | -164.41M | -148.25M | -140.15M | -127.81M | -115.15M | -120.34M | -97.47M | -70.2M | -56.81M | 7.69M | -9.88M | -31.99M |
Interest Income | 18.65M | 19.62M | 19.79M | 19.41M | 18.94M | 18.97M | 18.87M | 17.83M | 15.24M | 11.69M | 7.55M | 3.78M | 1.58M | 578K | 431K | 739K | 1.3M | 2.26M |
Pretax Income | -132.52M | -140.58M | -145.23M | -165.65M | -170.11M | -163.3M | -163.62M | -147.8M | -143.99M | -136.7M | -128.7M | -134.85M | -108.01M | -75.89M | -57.8M | 8.39M | -8.71M | -29.83M |
Net Income | -132.59M | -140.62M | -145.23M | -165.66M | -170.12M | -163.3M | -167.81M | -152.01M | -152.07M | -149.54M | -141.85M | -147.98M | -117.27M | -80.39M | -57.8M | 8.39M | -8.71M | -29.83M |
Selling & General & Admin | 45.04M | 43.74M | 41.51M | 41.59M | 41.2M | 43.02M | 41.95M | 41.08M | 39.77M | 37.26M | 36.64M | 32.63M | 29.2M | 26.27M | 21.49M | 21.19M | 20.55M | 19.99M |
Research & Development | 163.66M | 167.82M | 163.52M | 154.46M | 143.13M | 134.21M | 132.28M | 122.13M | 113.32M | 101.24M | 88.8M | 92.2M | 92.36M | 96.83M | 98.5M | 93.29M | 90.61M | 83.24M |
Other Expenses | n/a | n/a | -2K | 7.34M | 7.34M | 7.34M | 7.34M | -4K | -1K | 2K | 12K | 17K | 46K | 40K | 37K | -39K | -128K | -102K |
Operating Expenses | 208.7M | 211.56M | 205.03M | 196.05M | 184.32M | 177.23M | 174.23M | 163.21M | 153.09M | 138.5M | 125.44M | 124.83M | 121.56M | 123.1M | 119.99M | 114.48M | 111.16M | 103.23M |
Interest Expense | 70.48M | 61.83M | 50.09M | 37.64M | 26.66M | 20.06M | 18.08M | 17.38M | 19.08M | 20.59M | 21.11M | 18.31M | 12.17M | 6.3M | 1.45M | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | -441K | -883K | -883K | -883K | -442K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 209.3M | 212.16M | 206.23M | 197.25M | 185.52M | 177.83M | 174.23M | 163.21M | 153.09M | 138.5M | 125.44M | 124.83M | 121.56M | 123.1M | 119.99M | 114.48M | 111.16M | 103.23M |
Income Tax Expense | 77K | 47K | 3K | 4.88M | 4.88M | 4.87M | 9.06M | 4.21M | 8.08M | 12.84M | 13.15M | 13.13M | 9.2M | 4.44M | -64K | -139K | -131K | -105K |
Shares Outstanding (Basic) | 28.81M | 30.64M | 28.38M | 28.89M | 27.36M | 26.8M | 26.59M | 26.55M | 26.63M | 27.95M | 28.45M | 28.29M | 28.2M | 27.71M | 27.53M | 27.44M | 27.39M | 27.36M |
Shares Outstanding (Diluted) | 28.81M | 30.64M | 28.38M | 28.89M | 27.36M | 26.8M | 26.59M | 26.55M | 26.63M | 27.95M | 28.45M | 28.29M | 28.2M | 27.71M | 27.53M | 27.44M | 27.39M | 27.36M |
EPS (Basic) | -4.53 | -4.9 | -5.26 | -6.08 | -6.35 | -6.14 | -6.23 | -5.57 | -5.48 | -5.3 | -5.04 | -5.29 | -4.21 | -2.91 | -2.1 | 0.31 | -0.32 | -1.09 |
EPS (Diluted) | -4.53 | -4.9 | -5.26 | -6.08 | -6.35 | -6.14 | -6.23 | -5.57 | -5.48 | -5.3 | -5.04 | -5.29 | -4.21 | -2.91 | -2.1 | 0.31 | -0.32 | -1.09 |
EBITDA | -66.55M | -83.27M | -92.74M | -125.61M | -141.06M | -140.85M | -143.16M | -128.04M | -122.54M | -113.75M | -105.26M | -114.72M | -93.93M | -67.46M | -54.67M | 10.11M | -8.09M | -30.94M |
EBIT | -62.03M | -78.75M | -95.14M | -128.01M | -143.45M | -143.24M | -145.54M | -130.42M | -124.91M | -116.11M | -107.59M | -116.14M | -95.44M | -69.19M | -55.95M | 8.39M | -8.71M | -29.83M |
Depreciation & Amortization | 2.4M | 2.4M | 2.4M | 2.4M | 2.4M | 2.39M | 2.38M | 2.38M | 2.37M | 2.35M | 2.33M | 2.11M | 2.2M | 2.54M | 2.09M | 1.85M | 1.32M | 544K |